Leading the way to improve the lives of patients with type 1 diabetes
The Elizabeth Weiser Caswell Diabetes Institute, in partnership with JDRF, is using team science to pursue type 1 diabetes (T1D) cures and reduce disease burden through improved treatments
Watch
Our research advances knowledge, translating into
better care and patient perspectives
[image_hotspot_parent image=”https://secureservercdn.net/198.71.233.51/1z9.1b0.myftpupload.com/wp-content/uploads/Group-2814.png” alt=”Projects overview figure” _builder_version=”4.5.1″ module_alignment=”center”][/image_hotspot_parent]
Our team science approach in action
Our projects are aligned with a patient-centered focus to understand and modulate the metobolic environment of beta cells to improve T1D patient outcomes. Our projects connect data from multiple disciplines via a common data portal to inform research across projects.
*Metabotype respresents the integrative metabolic profile of an individual.
Who We Are
Leadership
Tom Gardner, MD, MS
Matthias Kretzler, MD
Scott Soleimanpour, MD
Lonnie Shea, PhD
Rodica Pop-Busui, MD, PhD
Subramaniam Pennathur, MD
